Literature DB >> 9422519

Differential expression of the MT-1E gene in estrogen-receptor-positive and -negative human breast cancer cell lines.

J A Friedline1, S H Garrett, S Somji, J H Todd, D A Sens.   

Abstract

The goal of this study was to determine which of the 10 functional metallothionein (MT) genes are expressed in four human breast cancer cell lines and whether expression varies among the cell lines. Using reverse transcription polymerase chain reaction (RT-PCR) technology, it was shown that there was no expression of mRNA for the MT-1A, MT-1B, MT-1F, MT-1G, MT-1H, MT-3, and MT-4 genes in any of the four cell lines. All four cell lines were shown to express mRNA for the MT-2A and MT-1X genes. The expression level of mRNA for the MT-2A gene demonstrated modest differences among the cell lines, whereas expression of the MT-1X gene was consistent. In contrast, mRNA for the MT-1E gene was expressed in only two of the four cell lines and expression correlated to the estrogen receptor status of the cell lines. The two estrogen-receptor-positive cell lines showed no mRNA expression for the MT-1E gene. In the two estrogen-receptor-negative cell lines, mRNA expression for the MT-1E gene was elevated with expression levels similar to the housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase. The cellular content of MT protein was also shown to be elevated in the estrogen-receptor-negative cell lines that express MT-1E mRNA. These results suggest a possible relationship between estrogen receptor status and MT-1E gene expression in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422519      PMCID: PMC1858136     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Structure and expression of two human metallothionein-I isoform genes and a related pseudogene.

Authors:  C J Schmidt; M F Jubier; D H Hamer
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

2.  Metallothionein expression in duct carcinoma in situ of the breast.

Authors:  A G Douglas-Jones; K W Schmid; B Bier; K Horgan; K Lyons; N D Dallimore; I J Moneypenny; B Jasani
Journal:  Hum Pathol       Date:  1995-02       Impact factor: 3.466

3.  Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases.

Authors:  T Haerslev; K Jacobsen; L Nedergaard; K Zedeler
Journal:  Pathol Res Pract       Date:  1994-08       Impact factor: 3.250

4.  Localization of metallothionein in breast carcinomas. An immunohistochemical study.

Authors:  M Fresno; W Wu; J M Rodriguez; M Nadji
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Cell specificity and an effect of ras on human metallothionein gene expression.

Authors:  C J Schmidt; D H Hamer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Characterisation of six additional human metallothionein genes.

Authors:  F A Stennard; A F Holloway; J Hamilton; A K West
Journal:  Biochim Biophys Acta       Date:  1994-08-02

7.  Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast.

Authors:  K W Schmid; I O Ellis; J M Gee; B M Darke; W E Lees; J Kay; A Cryer; J M Stark; A Hittmair; D Ofner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.

Authors:  B Bier; A Douglas-Jones; M Tötsch; B Dockhorn-Dworniczak; W Böcker; B Jasani; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.

Authors:  Y Y Yang; E S Woo; C E Reese; R R Bahnson; N Saijo; J S Lazo
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

10.  Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia.

Authors:  C J Quaife; S D Findley; J C Erickson; G J Froelick; E J Kelly; B P Zambrowicz; R D Palmiter
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162

View more
  12 in total

1.  Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers.

Authors:  Paweł Surowiak; Piotr Paluchowski; Teresa Wysocka; Andrzej Wojnar; Maciej Zabel
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

2.  Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.

Authors:  Siew-Kian Tai; Owen June-Keong Tan; Vincent Tak-Kwong Chow; Rongxian Jin; J Louise Jones; Puay-Hoon Tan; Anita Jayasurya; Boon-Huat Bay
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

3.  Quantitation of human metallothionein isoforms: a family of small, highly conserved, cysteine-rich proteins.

Authors:  Aaron A Mehus; Wallace W Muhonen; Scott H Garrett; Seema Somji; Donald A Sens; John B Shabb
Journal:  Mol Cell Proteomics       Date:  2014-02-03       Impact factor: 5.911

4.  Functional analysis of the transcription repressor PLU-1/JARID1B.

Authors:  Angelo G Scibetta; Samantha Santangelo; Julia Coleman; Debbie Hall; Tracy Chaplin; John Copier; Steve Catchpole; Joy Burchell; Joyce Taylor-Papadimitriou
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

5.  Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.

Authors:  Y Wu; M S Siadaty; M E Berens; G M Hampton; D Theodorescu
Journal:  Oncogene       Date:  2008-08-25       Impact factor: 9.867

6.  Metallothionein isoform 3 as a potential biomarker for human bladder cancer.

Authors:  M A Sens; S Somji; D L Lamm; S H Garrett; F Slovinsky; J H Todd; D A Sens
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

7.  Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.

Authors:  R Jin; B H Bay; V T Chow; P H Tan; V C Lin
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

8.  Potential role of p53 on metallothionein induction in human epithelial breast cancer cells.

Authors:  L Z Fan; M G Cherian
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

9.  The unique C- and N-terminal sequences of Metallothionein isoform 3 mediate growth inhibition and Vectorial active transport in MCF-7 cells.

Authors:  Brent Voels; Liping Wang; Donald A Sens; Scott H Garrett; Ke Zhang; Seema Somji
Journal:  BMC Cancer       Date:  2017-05-25       Impact factor: 4.430

10.  Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer.

Authors:  Rohit R Jadhav; Zhenqing Ye; Rui-Lan Huang; Joseph Liu; Pei-Yin Hsu; Yi-Wen Huang; Leticia B Rangel; Hung-Cheng Lai; Juan Carlos Roa; Nameer B Kirma; Tim Hui-Ming Huang; Victor X Jin
Journal:  Clin Epigenetics       Date:  2015-02-24       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.